In COSMIC, the KRAS G12D and G12V mutations are reported to occur in 3.3% and 4.1% of lung adenocarcinomas but were detected in 47.6% and 57.1% of lung adenocarcinomas analyzed by ACB‐PCR, respectively (Myers et al. 2015). Here, KRAS is linked to lung adenocarcinoma.